Overview

Add-on Study on Solidarity Trial Plus in Nepal

Status:
Recruiting
Trial end date:
2022-12-01
Target enrollment:
Participant gender:
Summary
Proposal for Sub-Study to be conducted with the WHO Solidarity Plus Trial: Apart from the data been collected as per the WHO Solidarity Trial Plus protocol, Nepal Health Research Council will conduct a sub-study to evaluate some components which are felt to be important in the local context but have not been included as part of the Solidarity Trial Plus. Rather that conducting a separate study, the following components can be evaluated by collecting additional data as a part of sub-study in the local context.
Phase:
Phase 4
Details
Lead Sponsor:
Nepal Health Research Council
Collaborator:
World Health Organization
Treatments:
Artesunate
Infliximab